T.K. Birkenhager

Dr. T.K. Birkenhager is a researcher in the Department of Psychiatry at Erasmus MC, Netherlands. He is actively involved in clinical and translational research focused on electroconvulsive therapy (ECT), antidepressant treatments, and the management of major depressive disorders. His work spans both pharmacological and procedural aspects of psychiatric care, with a strong emphasis on treatment efficacy, safety, and healthcare policy.

Research Interests:

• Electroconvulsive Therapy (ECT) and its complications, including intracranial pressure changes and postictal agitation
• Remission and relapse dynamics in major depressive disorder
• Psychopharmacology, particularly antidepressants and drug shortages
• Health policy and organization of psychiatric services in the Netherlands and Belgium
• Clinical outcomes and prognostic factors in mood disorders

The recent articles by Dr. Birkenhager show a consistent focus on ECT-related challenges, including safety, agitation, remission maintenance, and systemic issues in psychiatric care. His work combines clinical observation, systematic reviews, and policy analysis, reflecting a multidisciplinary approach to improving mental health treatment.

Scientific Contributions:

• Published over 135 research outputs, including articles, reviews, editorials, and chapters
• Active in knowledge dissemination through editorials on psychotropic drug shortages
• Engaged in collaborative research across institutions and disciplines

Advising and Grants: While specific students and grant details are not listed, Dr. Birkenhager has supervised academic work (3 items), indicating mentorship activity. There is no mention of specific grants or funding sources in the provided text.

Labs and Teams: He collaborates with a multidisciplinary team involving neurologists, intensivists, and psychiatrists, particularly in studies on ECT-induced physiological changes. His network includes researchers from Erasmus MC and external partners in Belgium and the Netherlands.